RNA Diagnostics | RNA Diagnostics

Paul Lucas joins the Board of Directors at Rna Diagnostics Inc.

by RNA Diagnostics | Feb 18, 2016 | Uncategorized

Rna Diagnostics Inc. announced today that Paul Lucas, an accomplished veteran of the Life Sciences industry, has joined the Company’s Board of Directors. “Paul brings a wealth of proven business and Life Science innovation insight to Rna Diagnostics,” said Dr. Ken...

Rna Diagnostics “Breaking the Mold” at World Cancer Day event hosted by the Ontario Institute for Cancer Research and MaRS

by RNA Diagnostics | Feb 12, 2016 | Uncategorized

The Ontario Institute for Cancer Research and MaRS Discovery District hosted an event for World Cancer Day under the banner of “Breaking the Mold: Rethinking the Cancer System.” Hosted by André Picard, Health Columnist of The Globe and Mail, the panel consisted of...

Rna Diagnostics announces new study in chemotherapy efficacy in canine lymphoma in partnership with University of Guelph’s Ontario Veterinary College and supported by $100,000 grant from the Ontario Centres of Excellence

by RNA Diagnostics | Jan 21, 2016 | Uncategorized

Rna Diagnostics Inc announced today a new study to investigate RDA as a predictor for chemotherapy efficacy in canine lymphoma in partnership with University of Guelph Institute for Comparative Cancer Investigation and the Mona Campbell Centre for Animal Cancer at the...

RDA™ Evolves into Platform Technology

by RNA Diagnostics | Nov 18, 2015 | Uncategorized

While the primary focus of RNA Disruption Assay (RDA) continues to be breast cancer chemotherapy management, it is rapidly evolving into a platform technology that will be utilized in the management of treatments across multiple cancers. RDA is now being employed in...

RNA Disruption Assay (RDA™ ) appears superior to a pCR as a chemotherapy response biomarker

by RNA Diagnostics | Sep 10, 2015 | Uncategorized

Rna Diagnostics announces the study, Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy, recently published in Breast Cancer Research and Treatment. Rna Diagnostics is a Canadian cancer diagnostics company developing diagnostic tools to...

« Older Entries

Next Entries »

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.